BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29681408)

  • 1. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Biancari F; Romppanen H; Savontaus M; Siljander A; Mäkikallio T; Piira OP; Piuhola J; Vilkki V; Ylitalo A; Vasankari T; Airaksinen JKE; Niemelä M
    Int J Cardiol; 2018 Jul; 263():29-31. PubMed ID: 29681408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.
    Moriyama N; Lindström L; Laine M
    EuroIntervention; 2019 Feb; 14(15):e1558-e1565. PubMed ID: 30295293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided deployment of ProGlide™ device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study.
    Ross DS; Nogic J; Cong H; Nuzzi V; Thanikachalam P; Veenuraju S; Gruner-Hegge N; Anwar M; O'Sullivan M; Costopoulos C; Davies WR; Costanzo P
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):771-781. PubMed ID: 38451155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
    Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation.
    Honda Y; Araki M; Yamawaki M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Hirano K; Ito Y
    J Interv Cardiol; 2018 Apr; 31(2):216-222. PubMed ID: 29193337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Barbash IM; Wasserstrum Y; Erlebach M; Guetta V; Ziegelmüller J; Segev A; Fefer P; Maor E; Lange R; Ruge H
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):160-168. PubMed ID: 38059295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of percutaneous femoral arteriotomy closure using the MANTA
    De Palma R; Settergren M; Rück A; Linder R; Saleh N
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Complications in Transcatheter Aortic Valve Replacement With Plug-Based vs Suture-Based Closure Devices.
    Zornitzki L; Zahler D; Frydman S; Itach T; Ben-Shoshan J; Halkin A; Bazan S; Arbel Y; Konigstein M; Finkelstein A; Banai S; Steinvil A
    Can J Cardiol; 2023 Nov; 39(11):1528-1534. PubMed ID: 37419247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
    Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
    EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative Application Technique for the MANTA Vascular Closure Device for Percutaneous Large-Bore Arterial Access Closure: The Fluoroscopic DOT Technique.
    Memon S; Goldman S; Rodriguez R; Ramlawi B; Coady PM; Gnall EM
    J Endovasc Ther; 2023 Dec; 30(6):885-891. PubMed ID: 35766367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the MANTA device to rescue failed pre-closure following transfemoral transcatheter aortic valve implantation.
    Ali N; Blackman DJ; Cunnington M; Malkin CJ
    J Cardiol Cases; 2019 Mar; 19(3):81-84. PubMed ID: 30949246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
    Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Boussofara A; Godin M; Canville A; Baala B; Berland J; Koning R; Landolff Q
    Catheter Cardiovasc Interv; 2024 Mar; 103(4):650-659. PubMed ID: 38407552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide.
    Hoffmann P; Al-Ani A; von Lueder T; Hoffmann J; Majak P; Hagen O; Loose H; Kløw NE; Opdahl A
    CVIR Endovasc; 2018; 1(1):20. PubMed ID: 30652151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation.
    Gmeiner JMD; Linnemann M; Steffen J; Scherer C; Orban M; Theiss H; Mehilli J; Sadoni S; Peterß S; Joskowiak D; Hagl C; Tsilimparis N; Curta A; Maurus S; Doldi PM; Löw K; Haum M; Roden D; Hausleiter J; Massberg S; Rizas K; Deseive S; Braun D
    EuroIntervention; 2022 Nov; 18(10):812-819. PubMed ID: 35903846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of closure devices on vascular complication and mortality rates in TAVI procedures.
    Dimitriadis Z; Scholtz W; Börgermann J; Wiemer M; Piper C; Vlachojannis M; Gummert J; Horstkotte D; Ensminger S; Faber L; Scholtz S
    Int J Cardiol; 2017 Aug; 241():133-137. PubMed ID: 28153535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation.
    Carande EJ; Salim TS; Chase A; Sekar B; Aldalati O; Hailan A; Khurana A; Smith D; Obaid DR
    Br J Radiol; 2023 Dec; 96(1152):20230296. PubMed ID: 37747290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.